Medical XpressStem cells help researchers identify neuronal defects causing Angelman syndromeMedical XpressResearchers at UConn Health used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause t… Continue reading
Medical XpressStem cells help researchers identify neuronal defects causing …Medical XpressResearchers at UConn Health used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare … Continue reading
Science TimesGlobal Stem Cell Therapy Market – Analysis, Technologies and Forecasts to 2021 – Increasing Demand to Develop …Yahoo FinanceThe report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis wit… Continue reading
|
5 countries prioritizing stem cell treatments
Becker’s Orthopedic & Spine Five countries lead the way in stem cell medication clinical trials administered between 1999 and 2016, according to The National Institute of Food and Drug Safety in South Korea. Here are the five countries leading the way in stem cell clinical trials: 1. S. Korea World’s Second in No. of Stem Cell Clinical TrialsKBS WORLD Radio News |
|
Editas Medicine (EDIT) to Present New Data Showing Advancements for Translating CRISPR Technologies into …
StreetInsider.com “Editas Medicine is at the forefront of the rapidly-advancing science that is unlocking the potential of CRISPR for patients,” said Katrine Bosley, President and Chief Executive Officer, Editas Medicine. “These data at ASGCT showcase advances towards … |
|
Editas Medicine to Present New Data Demonstrating Advancements for Translating CRISPR Technologies into …
Yahoo Finance “Editas Medicine is at the forefront of the rapidly-advancing science that is unlocking the potential of CRISPR for patients,” said Katrine Bosley, President and Chief Executive Officer, Editas Medicine. “These data at ASGCT showcase advances towards … |
|
India Firm Gets Stem Cell Treatment Approved
https://ryortho.com/ (press release) (subscription) Mumbai-based Regenerative Medical Services Regrow (RMS Regrow) announces that it has received market authorization for India’s first cell therapy product, Chondron ACI, from Drug Controller General of India (DCGI), which works under the Central Drugs … |